Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
13.00
+2.21 (20.48%)
At close: Jun 12, 2026, 4:00 PM EDT
12.46
-0.54 (-4.15%)
Pre-market: Jun 15, 2026, 8:11 AM EDT
Sensei Biotherapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
17.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curis | 7.06M |
| Lipocine | 2.00M |
| Werewolf Therapeutics | 1.14M |
| Exicure | 500.00K |
| Vyome Holdings | 152.72K |
SNSE News
- 4 days ago - Sensei Biotherapeutics initiated with a Buy at BTIG - TheFly
- 5 days ago - Sensei Biotherapeutics Registration statement: Registration filing - Filings
- 10 days ago - Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 13 days ago - Sensei Biotherapeutics Registration statement: Registration filing - Filings
- 16 days ago - Sensei Biotherapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 17 days ago - Sensei Biotherapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 18 days ago - Sensei Biotherapeutics initiated with a Buy at Lucid Capital - TheFly
- 24 days ago - Sensei Biotherapeutics Proxy statement: Proxy filing - Filings